EP1003770A4 - Sekretierte polypeptide sowie diese kodierende polynukleotide - Google Patents

Sekretierte polypeptide sowie diese kodierende polynukleotide

Info

Publication number
EP1003770A4
EP1003770A4 EP98930279A EP98930279A EP1003770A4 EP 1003770 A4 EP1003770 A4 EP 1003770A4 EP 98930279 A EP98930279 A EP 98930279A EP 98930279 A EP98930279 A EP 98930279A EP 1003770 A4 EP1003770 A4 EP 1003770A4
Authority
EP
European Patent Office
Prior art keywords
polynucleotides encoding
secreted proteins
secreted
proteins
polynucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98930279A
Other languages
English (en)
French (fr)
Other versions
EP1003770A1 (de
Inventor
Kenneth Jacobs
John M Mccoy
Edward R Lavallie
Lisa A Racie
Maurice Treacy
Vikki Spaulding
Michael J Agostino
Steven H Howes
Kim Fechtel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute LLC filed Critical Genetics Institute LLC
Publication of EP1003770A1 publication Critical patent/EP1003770A1/de
Publication of EP1003770A4 publication Critical patent/EP1003770A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP98930279A 1997-06-19 1998-06-18 Sekretierte polypeptide sowie diese kodierende polynukleotide Withdrawn EP1003770A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US878715 1992-04-30
US98588 1993-07-28
US87871597A 1997-06-19 1997-06-19
US9858898A 1998-06-17 1998-06-17
PCT/US1998/012516 WO1998057976A1 (en) 1997-06-19 1998-06-18 Secreted proteins and polynucleotides encoding them

Publications (2)

Publication Number Publication Date
EP1003770A1 EP1003770A1 (de) 2000-05-31
EP1003770A4 true EP1003770A4 (de) 2002-10-30

Family

ID=26794899

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98930279A Withdrawn EP1003770A4 (de) 1997-06-19 1998-06-18 Sekretierte polypeptide sowie diese kodierende polynukleotide

Country Status (5)

Country Link
EP (1) EP1003770A4 (de)
JP (1) JP2002513294A (de)
AU (1) AU7970498A (de)
CA (1) CA2294569A1 (de)
WO (1) WO1998057976A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1238281A2 (de) * 1999-12-01 2002-09-11 Ludwig Institute For Cancer Research Mit krebs verbundeten antigenen und verwendungen dafür
JP5504562B2 (ja) * 2006-12-20 2014-05-28 東レ株式会社 癌の検出方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4798885A (en) * 1986-02-07 1989-01-17 Genentech, Inc. Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain
US5770209A (en) * 1991-08-30 1998-06-23 University Of South Florida Acceleration of wound healing using connective tissue growth factor
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
CA2166278A1 (en) * 1993-06-29 1995-01-12 Denis J. Gospodarowicz A truncated keratinocyte growth factor (kgf) having increased biological activity
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby
US5708157A (en) * 1996-07-26 1998-01-13 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US5792628A (en) * 1997-03-14 1998-08-11 Bowman; Michael Secreted protein, BA3.1, and polynucleotides encoding same

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 30 June 1993 (1993-06-30), XP002209843, Database accession no. L20259 *
DATABASE EMBL [online] XP002209844, Database accession no. L14938 *
DATABASE EMBL [online] XP002209845, Database accession no. AB007912 *
OKAZAKI TAKASHI ET AL: "Molecular diversity of the SCG10/stathmin gene family in the mouse.", GENOMICS, vol. 18, no. 2, 1993, pages 360 - 373, XP002209842, ISSN: 0888-7543 *
See also references of WO9857976A1 *

Also Published As

Publication number Publication date
JP2002513294A (ja) 2002-05-08
EP1003770A1 (de) 2000-05-31
CA2294569A1 (en) 1998-12-23
AU7970498A (en) 1999-01-04
WO1998057976A1 (en) 1998-12-23

Similar Documents

Publication Publication Date Title
AU6050898A (en) Secreted proteins and polynucleotides encoding them
AU6578398A (en) Secreted proteins and polynucleotides encoding them
AU6777298A (en) Secreted proteins and polynucleotides encoding them
AU7159898A (en) Secreted proteins and polynucleotides encoding them
AU7807298A (en) Secreted proteins and polynucleotides encoding them
AU6702298A (en) Secreted proteins and polynucleotides encoding them
AU1101199A (en) Secreted proteins and polynucleotides encoding them
AU7142498A (en) Secreted proteins and polynucleotides encoding them
EP1056764A4 (de) Sekretierte proteine und für sie kodierende polynukleotide
AU1417899A (en) Secreted proteins and polynucleotides encoding them
EP1075487A4 (de) Sekretierte proteine und für diese kodierende polynukleotide
AU6337398A (en) Secreted proteins and polynucleotides encoding them
AU5828398A (en) Secreted proteins and polynucleotides encoding them
AU6590898A (en) Secreted proteins and polynucleotides encoding them
EP1012261A4 (de) Ausgeschiedene proteine und für diese kodierende polynukleotide
AU5801998A (en) Secreted proteins and polynucleotides encoding them
AU6546898A (en) Secreted proteins and polynucleotides encoding them
EP1040118A4 (de) Proteinsekret und die enstprechenden es kodierenden Polynucleotide
AU7826498A (en) Secreted proteins and polynucleotides encoding them
AU2997299A (en) Secreted proteins and polynucleotides encoding them
EP1017719A4 (de) Sekretierte proteine und polynukleotide, die für diese kodieren
AU6765098A (en) Secreted proteins and polynucleotides encoding them
EP1003770A4 (de) Sekretierte polypeptide sowie diese kodierende polynukleotide
EP1032652A4 (de) Sekretierte proteine und für diese kodierende polynukleotide
AU6439598A (en) Secreted proteins and polynucleotides encoding them

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000119

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HOWES, STEVEN, H.

Inventor name: AGOSTINO, MICHAEL, J.

Inventor name: SPAULDING, VIKKI

Inventor name: TREACY, MAURICE

Inventor name: RACIE, LISA, A.

Inventor name: LAVALLIE, EDWARD, R.

Inventor name: MCCOY, JOHN, M.

Inventor name: JACOBS, KENNETH

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HOWES, STEVEN, H.

Inventor name: AGOSTINO, MICHAEL, J.

Inventor name: SPAULDING, VIKKI

Inventor name: TREACY, MAURICE

Inventor name: RACIE, LISA, A.

Inventor name: LAVALLIE, EDWARD, R.

Inventor name: MCCOY, JOHN, M.

Inventor name: JACOBS, KENNETH

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: GENETICS INSTITUTE, LLC

A4 Supplementary search report drawn up and despatched

Effective date: 20020916

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20030131